Clinical Trials Directory

Trials / Completed

CompletedNCT04673877

Vancomycin Tissue Concentrations by Bier Block or Intravenous Administration

Tissue Concentrations of Vancomycin Achieved With Bier Block Administration Versus Intravenous Prophylaxis in Upper Extremity Surgery: A Randomized Controlled Trial

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether or not giving a lower dose of antibiotics (Vancomycin) in the area where it is needed (upper extremity) is more effective at preventing infection than the current standard dose which is given intravenously (IV).

Conditions

Interventions

TypeNameDescription
DRUGSystemic IV Vancomycin1 g of vancomycin will be delivered intravenously over a period of one hour prior to tourniquet inflation.
PROCEDUREBier BlockAfter exsanguination of the limb and elevation of the tourniquet in the prepped and draped patient, Vancomycin will be injected into a superficial vein in the hand, wrist or forearm.
DRUGVancomycin500 mg diluted in 50 cc normal saline of injection into superficial vein in the hand, wrist or forearm

Timeline

Start date
2021-08-26
Primary completion
2022-08-17
Completion
2022-08-17
First posted
2020-12-17
Last updated
2022-10-07

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04673877. Inclusion in this directory is not an endorsement.